Meeting
2021 ASCO Annual Meeting
Incidence, timing, and predictors of CNS metastasis in patients (Pts) with clinically localized cutaneous melanoma (CM).
Authors
Merve Hasanov
The University of Texas MD Anderson Cancer Center, Houston, TX
Merve Hasanov , Denai R. Milton , Sapna Pradyuman Patel , Hussein Abdul-Hassan Tawbi , Isabella Claudia Glitza , Sherise D. Ferguson , Debora Alexandra Ledesma , Carlos A. Torres-Cabala , Alexander J. Lazar , Elizabeth M. Burton , Jeffrey E. Gershenwald , Lauren Elaine Haydu , Michael A. Davies
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9580)
DOI
10.1200/JCO.2021.39.15_suppl.9580
Abstract #
9580
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Plasma methylated DNA markers of cutaneous melanoma: Association with PET/CT-positive disease.
First Author: Alexander Meves
Poster
2021 ASCO Annual Meeting
The risk and tropism of central nervous system metastases (CNS) in patients with stage II cutaneous melanoma.
First Author: Paul Johannet
Poster
2024 ASCO Breakthrough
Early circulating tumor DNA (ctDNA) changes during treatment with immune checkpoint inhibitors (ICI) as a predictor of clinical outcomes in patients (pts) with advanced stage melanoma/skin cancer.
First Author: Vincent T. Ma
